What you can learn from percent free PSA testing

Steven R. Potter, Alan Wayne Partin

Research output: Contribution to journalArticle

Abstract

Percent free PSA has emerged as perhaps the most clinically useful of the molecular forms of PSA, with the potential to improve early detection, staging, and monitoring of prostate cancer. Our experts explain when to use this valuable test and how to interpret the information it provides.

Original languageEnglish (US)
Pages (from-to)94-108
Number of pages15
JournalPatient Care
Volume34
Issue number5
StatePublished - 2000

Fingerprint

Prostatic Neoplasms

ASJC Scopus subject areas

  • Leadership and Management

Cite this

What you can learn from percent free PSA testing. / Potter, Steven R.; Partin, Alan Wayne.

In: Patient Care, Vol. 34, No. 5, 2000, p. 94-108.

Research output: Contribution to journalArticle

Potter, SR & Partin, AW 2000, 'What you can learn from percent free PSA testing', Patient Care, vol. 34, no. 5, pp. 94-108.
Potter, Steven R. ; Partin, Alan Wayne. / What you can learn from percent free PSA testing. In: Patient Care. 2000 ; Vol. 34, No. 5. pp. 94-108.
@article{f0762a2a374f493b99552205e8627634,
title = "What you can learn from percent free PSA testing",
abstract = "Percent free PSA has emerged as perhaps the most clinically useful of the molecular forms of PSA, with the potential to improve early detection, staging, and monitoring of prostate cancer. Our experts explain when to use this valuable test and how to interpret the information it provides.",
author = "Potter, {Steven R.} and Partin, {Alan Wayne}",
year = "2000",
language = "English (US)",
volume = "34",
pages = "94--108",
journal = "Patient Care",
issn = "0031-305X",
publisher = "Advanstar Communications",
number = "5",

}

TY - JOUR

T1 - What you can learn from percent free PSA testing

AU - Potter, Steven R.

AU - Partin, Alan Wayne

PY - 2000

Y1 - 2000

N2 - Percent free PSA has emerged as perhaps the most clinically useful of the molecular forms of PSA, with the potential to improve early detection, staging, and monitoring of prostate cancer. Our experts explain when to use this valuable test and how to interpret the information it provides.

AB - Percent free PSA has emerged as perhaps the most clinically useful of the molecular forms of PSA, with the potential to improve early detection, staging, and monitoring of prostate cancer. Our experts explain when to use this valuable test and how to interpret the information it provides.

UR - http://www.scopus.com/inward/record.url?scp=24644506338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644506338&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:24644506338

VL - 34

SP - 94

EP - 108

JO - Patient Care

JF - Patient Care

SN - 0031-305X

IS - 5

ER -